Trial Profile
The Clinical Trial for Three Consecutive Lots of Influenza Split Vaccine Anflu by Randomized, Double-Blind and Controlled Design
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2016
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sinovac Biotech
- 20 Nov 2007 New trial record.